We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Clinical Trial Assessing Treatments for Preventing People at High Risk From Developing Multidrug-resistant TB Launches

News   Jun 25, 2019 | Original story from NIH

 
Clinical Trial Assessing Treatments for Preventing People at High Risk From Developing Multidrug-resistant TB Launches

Scanning electron micrograph of Mycobacterium tuberculosis bacteria, which cause TB. Credit: NIAID

 
 
 

RELATED ARTICLES

How Do Enteroviruses Infect?

News

Enteroviruses are one of the most common human pathogens but the physiological events leading to successful enterovirus infection are still poorly understood. But new light has been shed on the role of albumin and ions in host cell vesicles that promote genome release and efficient infection.

READ MORE

Study Suggests a Lack of Racial Diversity in Cancer Drug Trials

News

A new study has found that fewer than 8% of cancer drug trials reported participation from the four major races in the United States – white, Asian, black and Hispanic – between 2008 and 2018.

READ MORE

Grant Fuels Drug Discovery Efforts for ALS

News

Scientists have received a $3.1 million grant to collaborate and investigate drug therapies for amyotrophic lateral sclerosis (ALS).

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE